Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Artiva Biotherapeutics, Inc. Common Stock
ARTVCurrent price
10.51 USD
-1.44 USD (-12.05%)
Last closed
11.7 USD
Company
www.artivabio.com
ISIN
unknown
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
318 403 872 USD
Yield for 12 month
-12.42 %
1Y
3Y
5Y
10Y
15Y
ARTV
Artiva Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing natural killer (NK) cell-based therapies for patients suffering from autoimmune diseases and cancers. The company's lead product candidate is AB-101, an off-the-shelf NK cell therapy for patients with autoimmune diseases and cancers, such as lupus nephritis, rheumatoid arthritis, pemphigus vulgaris, the anti-neutrophil cytoplasmic antibody-associated vasculitis subtypes granulomatosis with polyangiitis/microscopic polyangiitis, systemic lupus erythematosus, and B-cell-non-Hodgkin lymphoma. It also develops AB-201, an allogeneic anti- human epidermal growth factor receptor 2 chimeric antigen receptor (CAR)-NK cell product candidate; and AB-205, an allogeneic anti-CD5 CAR-NK cell product candidate. The company was incorporated in 2019 and is headquartered in San Diego, California. Address: 5505 Morehouse Drive, San Diego, CA, United States, 92121
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
21.25 USDP/E ratio
–Dividend Yield
–Current Year
+33 492 000 USD
Last Year
+4 931 000 USD
Current Quarter
–
Last Quarter
+251 000 USD
Current Year
+33 492 000 USD
Last Year
+4 931 000 USD
Current Quarter
–
Last Quarter
+251 000 USD
Key Figures ARTV
1 year
3 years
5 years
10 years
EBITDA
-29 501 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
–
PEG Ratio
–
Return On Equity TTM
-44.21 %
Wall Street Target Price
21.25 USD
Revenue TTM
29 256 000 USD
Book Value
-234.71 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-74.6 %
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-0.93 USD
Diluted Eps TTM
-0.93 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-111.17 %
Dividend Analytics ARTV
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ARTV
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation ARTV
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
8.4445
Price Sales TTM
10.8834
Enterprise Value EBITDA
–
Price Book MRQ
–
Financials ARTV
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators ARTV
For 52 weeks
9.68 USD
17.31 USD
50 Day MA
12.51 USD
Shares Short Prior Month
840 866
200 Day MA
12.03 USD
Short Ratio
3.53
Shares Short
940 524
Short Percent
3.9 %
BeatStart